发明名称 HETEROARYLS AND USES THEREOF
摘要 The present invention provides a compound of formula I:;wherein R1, X1, X2, R2, R3, R4, R5, n, and m are as described in the specification. Such compounds are inhibitors of VPS34 and thus useful for treating proliferative, inflammatory, or cardiovascular disorders.
申请公布号 US2016333007(A1) 申请公布日期 2016.11.17
申请号 US201515111429 申请日期 2015.01.13
申请人 MILLENNIUM PHARMACEUTICALLS, INC. 发明人 BHARATHAN INDU T.;BLACKBURN Chris;CIAVARRI Jeffrey P.;CHOUITAR Jouhara;CILLIS Courtney A.;D'AMORE Natalie;FLE,OMG Paul E.;GIGSTAD Kenneth M.;GIPSON Kirsta E.;GIRARD Mario;HU Yongbo;LEE Janice;LI Gang;REZAEI Mansoureh;SINTCHAK Michael D.;SOUCY Francois;STROUD Stephen g.;VOS Tricia J.;XU He;YE Yingchun
分类号 C07D471/04;A61K31/444;A61K31/506;A61K45/06 主分类号 C07D471/04
代理机构 代理人
主权项 1. A compound of formula Ior a pharmaceutically acceptable salt thereof, wherein: each of X1 and X2, independently, is N, CH, or CR4; L1 is a bond, —C(O)—, —C(O)—O—, —S(O)2—, —C(O)N(Ra)—, or —S(O)2N(Ra)—; wherein each Ra, independently, is hydrogen or C1-4 alkyl; wherein when L1 is a bond and R3 is phenyl, naphthyl, or heteroaryl, R2 optionally joins with R7 to form an optionally substituted 5-7-membered heterocyclyl or an optionally substituted 5-6-membered heteroaryl; R1 is hydrogen or -L2-R6 wherein: L2 is C1-4 alkylene, —C(O)—, —C(O)—O—, —S(O)—, —S(O)2—, —C(O)N(Rb)—, or —S(O)2N(Rb)—; wherein each Rb, independently, is hydrogen or C1-4 alkyl; andR6 is hydrogen, C1-6 aliphatic, 3-10-membered cycloaliphatic, phenyl, naphthyl, 3-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or 5-10-membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which being optionally substituted with 1-5 R7; or Rb and R6 combine to form a 3-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur wherein said heterocyclyl is optionally substituted with 1-5 R7; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen, C1-6 aliphatic, 3-10-membered cycloaliphatic, phenyl, naphthyl, 3-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or 5-10-membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; provided that if R3 is hydrogen, L1 is a bond; each of R3 being optionally substituted with 1-5 R7 wherein: each R7 independently is —CN, halo, or -L3-R8 wherein: L3 is a bond, C1-4 aliphatic, —O—, —N(Rc)—, —S—, —S(O)—, —S(O)2—, —C(O)—, —C(O)O—, —C(O)N(Rc)—, —N(Rc)C(O)—, —N(Rc)C(O)O—, —S(O)2NRc, —N(Rc)S(O)2—, —OC(O)N(Rc)—, —N(Rc)C(O)N(Rd)—, —N(Rc)S(O)2N(Rd)—, or —OC(O)—;each occurrence of Rc and Rd, independently, is hydrogen or C1-4 alkyl, andR8 is hydrogen, C1-6 aliphatic, 3-10-membered cycloaliphatic, phenyl, naphthyl, 3-10-membered heterocyclyl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or 5-10-membered heteroaryl having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each occurrence of R4 and R5, independently, is —CN, halo, or -L4-R9 wherein: L4 is C1-4 alkylene, —O—, —N(Re)—, —S—, —S(O)—, —S(O)2—, —C(O)—, —CO2—, —C(O)N(Re)—, —N(Re)C(O)—, —N(Re)C(O)O—, —S(O)2N(Re)—, —N(Re)S(O)2—, —OC(O)N(Re)—, —N(Re)C(O)N(Rf)—, —N(Re)S(O)2N(Rf)—, or —OC(O)—;each occurrence of Re and Rf, independently, is hydrogen or C1-4 alkyl; andR9 is hydrogen, —NH2, or C1-6 aliphatic; m is 0-2; and n is 0-3.
地址 Cambidge MA US